Artículo

Development of a Mouse Model of Shiga Toxin 2 (STX2) Intoxication for Testing Therapeutic Agents against Hemolytic Uremic Syndrome (HUS).

Mejias, María PilarIcon ; Fernández Brando, Romina JimenaIcon ; Ramos, Maria VictoriaIcon ; Abrey Recalde, Maria JimenaIcon ; Zotta, Elsa; Meissl, Roberto Jose; Palermo, Marina SandraIcon
Fecha de publicación: 06/2016
Editorial: Bentham Science Publishers
Revista: Current Pharmaceutical Design
ISSN: 1381-6128
Idioma: Inglés
Tipo de recurso: Artículo publicado

Resumen

Hemolytic Uremic Syndrome (HUS) caused by infections with Shiga toxin (Stx)-producing E. coli is a life-threatening complication characterized by acute renal failure, thrombocytopenia and hemolytic anemia. Stx is the main pathogenic factor. Therefore, the mouse model by intravenous administration of a single lethal dose of Stx is often used to explore its pathogenic mechanisms. The aim of this work was to develop an alternative mouse model of Stx type 2 (Stx2) intoxication to evaluate new therapeutic strategies.

Archivos asociados

Documento no disponible
Tamaño: 1.560Mb
Formato: PDF
http://dx.doi.org/10.2174/1381612822666160628080350
http://www.eurekaselect.com/143667/article
info:eu-repo/semantics/restrictedAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Citación: Mejias, María Pilar; Fernández Brando, Romina Jimena; Ramos, Maria Victoria; Abrey Recalde, Maria Jimena; Zotta, Elsa; et al.; Development of a Mouse Model of Shiga Toxin 2 (STX2) Intoxication for Testing Therapeutic Agents against Hemolytic Uremic Syndrome (HUS).; Bentham Science Publishers; Current Pharmaceutical Design; 22; 34; 6-2016; 5294-5299
URI: http://hdl.handle.net/11336/47195
 

Comunidades y colecciones